CombiGene´s lead project CG01 has received funding from the European Union´s Horizon 2020 research and innovation programme

CombiGene and Cell and Gene Therapy Catapult sign agreement to develop manufacturing process for novel gene therapy to treat epilepsy

Jan 12, 2018

Collaboration between Cell and Gene Therapy Catapult (CGT Catapult) and Swedish gene therapy company CombiGene will take a unique therapy one step closer to helping sufferers of hard to treat epilepsy.
Read more >>